Correlation Between BiOasis Technologies and ATyr Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BiOasis Technologies and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BiOasis Technologies and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between biOasis Technologies and ATyr Pharma, you can compare the effects of market volatilities on BiOasis Technologies and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BiOasis Technologies with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BiOasis Technologies and ATyr Pharma.

Diversification Opportunities for BiOasis Technologies and ATyr Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BiOasis and ATyr is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding biOasis Technologies and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and BiOasis Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on biOasis Technologies are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of BiOasis Technologies i.e., BiOasis Technologies and ATyr Pharma go up and down completely randomly.

Pair Corralation between BiOasis Technologies and ATyr Pharma

Assuming the 90 days horizon biOasis Technologies is expected to generate 3.8 times more return on investment than ATyr Pharma. However, BiOasis Technologies is 3.8 times more volatile than ATyr Pharma. It trades about 0.05 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.04 per unit of risk. If you would invest  12.00  in biOasis Technologies on August 29, 2024 and sell it today you would lose (11.99) from holding biOasis Technologies or give up 99.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy76.36%
ValuesDaily Returns

biOasis Technologies  vs.  ATyr Pharma

 Performance 
       Timeline  
biOasis Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days biOasis Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BiOasis Technologies is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

BiOasis Technologies and ATyr Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BiOasis Technologies and ATyr Pharma

The main advantage of trading using opposite BiOasis Technologies and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BiOasis Technologies position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.
The idea behind biOasis Technologies and ATyr Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance